https://www.marketscreener.com/news/evercore-isi-starts-assa-abloy-coverage-at-in-line-ce7e50dedb8af426
Evercore ISI Starts Assa Abloy Coverage at In-line | MarketScreener
Apr 13, 2026 - Evercore ISI on Monday initiated coverage of Swedish access systems company Assa Abloy with an in-line rating and a price target of 395.00 kronor. ...
evercore isiassa abloyin linestartscoverage
https://www.einpresswire.com/article/603661111/royalty-pharma-to-present-at-evercore-isi-5th-annual-healthconx-virtual-conference
Royalty Pharma to Present at Evercore ISI 5th Annual HealthCONx Virtual Conference
Nov 28, 2022 - Royalty Pharma plc (Nasdaq: RPRX) today announced that it is scheduled to participate in a fireside chat at the Evercore ISI 5th Annual HealthCONx Virtual
royalty pharmaevercore isi
https://www.biospace.com/vaxcyte-to-present-at-evercore-isi-3rd-annual-healthconx-conference
Vaxcyte to Present at Evercore ISI 3rd Annual HealthCONx Conference - BioSpace
Nov 25, 2020 - Vaxcyte, Inc. announced that company management will participate in a fireside chat at the Evercore ISI 3rd Annual HealthCONx conference on Wednesday, December...
evercore isi3rd annualpresent
https://www.businesswire.com/news/home/20231120252274/en/Teva-to-Present-at-the-6th-Annual-Evercore-ISI-HealthCONx-Conference
Teva to Present at the 6th Annual Evercore ISI HealthCONx Conference
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at the Evercore ISI He...
the 6thevercore isitevapresent
https://www.merck.com/news/merck-to-present-at-the-evercore-isi-healthconx-conference-2019/
Merck to Present at the Evercore ISI HealthCONx Conference 2019 - Merck.com
Apr 28, 2026 - Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Michael Nally, chief marketing officer for Merck is scheduled to...
evercore isiconference 2019merckpresent
https://www.biospace.com/adamas-to-present-at-upcoming-evercore-isi-conference-nov-24-2020
Adamas to Present at Upcoming Evercore ISI Conference - Nov 24, 2020 - BioSpace
Nov 25, 2020 - Adamas Pharmaceuticals, Inc., a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological...
nov 24 2020evercore isi
https://www.biospace.com/sqz-biotech-to-present-at-evercore-isi-virtual-healthconx-conference
SQZ Biotech to Present at Evercore ISI Virtual HealthCONx Conference - BioSpace
Nov 23, 2020 - SQZ Biotechnologies (NYSE:SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today announced that Armon Sharei, PhD,...
evercore isisqzbiotechpresent
https://www.benzinga.com/analyst-ratings/24/01/36473897/what-to-know-about-evercore-isi-groups-upgrade-of-huntington-bancshares
What To Know About Evercore ISI Group's Upgrade of Huntington Bancshares - Huntington Bancshares...
what to knowevercore isi
https://www.biospace.com/switch-therapeutics-to-present-at-evercore-isi-2024-emerging-biotech-conference
Switch Therapeutics to Present at Evercore ISI 2024 Emerging Biotech Conference - BioSpace
Feb 22, 2024 - Switch Therapeutics today announced that Dee Datta, Ph.D., co-founder and CEO of Switch Therapeutics, will participate in a virtual fireside chat at the...
evercore isi
https://www.biospace.com/bd-to-present-at-evercore-isi-3rd-annual-healthconx-virtual-conference
BD to Present at Evercore ISI 3rd Annual HealthCONx Virtual Conference - BioSpace
Nov 20, 2020 - BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the Evercore ISI 3rd Annual...
evercore isi
https://www.businesswire.com/news/home/20211129005191/en/EQRx-to-Present-at-the-4th-Annual-Evercore-ISI-HealthCONx-Conference
EQRx to Present at the 4th Annual Evercore ISI HealthCONx Conference
EQRx, a new type of pharmaceutical company committed to developing and delivering important new medicines to patients at radically lower prices, today announ...
the 4thevercore isipresent
https://www.prnewswire.com/news-releases/azenta-to-participate-in-the-5th-annual-evercore-isi-healthconx-conference-301684278.html
Azenta to participate in the 5th Annual Evercore ISI HealthCONx Conference
/PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the virtual 5th Annual Evercore ISI HealthCONx...
to participatein the5th annualevercore isiazenta
https://www.biospace.com/springworks-therapeutics-to-participate-in-the-evercore-isi-healthconx-conference
SpringWorks Therapeutics to Participate in the Evercore ISI HealthCONx Conference - BioSpace
Nov 24, 2020 - SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with...
to participatein theevercore isispringworkstherapeutics
https://www.prnewswire.com/news-releases/theravance-biopharma-to-present-at-the-3rd-annual-evercore-isi-healthconx-conference-301174097.html
Theravance Biopharma to Present at the 3rd Annual Evercore ISI HEALTHCONx Conference
/PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH), a diversified biopharmaceutical company primarily focused on the discovery, development and...
the 3rd
https://www.biospace.com/apnimed-to-participate-in-the-upcoming-evercore-isi-2024-emerging-biotech-conference
Apnimed to Participate in the Upcoming Evercore ISI 2024 Emerging Biotech Conference - BioSpace
Jul 30, 2024 - Apnimed, Inc. today announced the company will participate in the Evercore ISI 2024 Emerging Biotech Conference taking place virtually on February 28-29, 2024.
https://finviz.com/news/313724/evercore-isi-raises-its-price-target-on-fox-corporation-fox-to-70-and-maintains-an-in-line-rating
Evercore ISI Raises its Price Target on Fox Corporation (FOX) to $70 and Maintains an In Line Rating
Stock screener for investors and traders, financial visualizations.
https://www.biospace.com/saghmos-therapeutics-announces-participation-in-the-evercore-isi-2024-emerging-private-biotech-conference
Saghmos Therapeutics Announces Participation in the Evercore ISI 2024 Emerging Private Biotech...
Feb 26, 2024 - Saghmos Therapeutics, Inc. (Saghmos), a privately held biopharmaceutical company focused on the prevention and treatment of cardiorenal complications,...
in the
https://www.marketscreener.com/news/evercore-isi-adjusts-pt-on-apollo-global-management-to-145-from-135-maintains-outperform-rating-ce7f59dad081f120
Evercore ISI Adjusts PT on Apollo Global Management to $145 From $135, Maintains Outperform Rating...
Apr 21, 2026 - Apollo Global Management Inc has an average rating of overweight and mean price target of $142.35, according to analysts polled by FactSet. ...
https://www.marketscreener.com/news/evercore-isi-adjusts-price-target-on-t-rowe-price-group-to-96-from-99-maintains-in-line-rating-ce7e50d8d181f721
Evercore ISI Adjusts Price Target on T. Rowe Price Group to $96 From $99, Maintains In Line Rating...
Apr 10, 2026 - T. Rowe Price Group has an average rating of underweight and mean price target of $92.58, according to analysts polled by FactSet. ...
https://www.marketscreener.com/news/evercore-isi-adjusts-price-target-on-jpmorgan-chase-to-340-from-320-maintains-outperform-rating-ce7e50d2de8af326
Evercore ISI Adjusts Price Target on JPMorgan Chase to $340 From $320, Maintains Outperform Rating...
https://www.biospace.com/shattuck-labs-to-present-virtually-at-evercore-isi-3rd-annual-healthconx-conference
Shattuck Labs to Present Virtually at Evercore ISI 3rd Annual HealthCONx Conference - BioSpace
Oct 3, 2024 - Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new...
https://www.biospace.com/bd-to-present-at-the-6th-annual-evercore-isi-healthconx-conference
BD to Present at the 6th Annual Evercore ISI HealthCONx Conference - BioSpace
Nov 15, 2023 - BD, a leading global medical technology company, announced that it will present at the 6th Annual Evercore ISI HealthCONx Conference on Tuesday, November 28,...
the 6th
https://www.marketscreener.com/news/evercore-isi-adjusts-price-target-on-henry-schein-to-90-from-100-maintains-outperform-rating-ce7e50dbd988ff24
Evercore ISI Adjusts Price Target on Henry Schein to $90 From $100, Maintains Outperform Rating |...
Apr 8, 2026 - Henry Schein has an average rating of overweight and mean price target of $89.23, according to analysts polled by FactSet. Price: 76.35, Change: +2.50, Percent...
https://stockhouse.com/news/press-releases/2025/11/26/immunic-to-participate-in-the-8th-annual-evercore-isi-healthcare-conference-in
2025-11-26 | Immunic to Participate in the 8th Annual Evercore ISI Healthcare Conference in...
(2025-11-26 | NDAQ:IMUX) Immunic to Participate in the 8th Annual Evercore ISI Healthcare Conference in December
https://www.biospace.com/molecular-partners-to-participate-in-the-evercore-isi-3rd-annual-healthconx-conference
Molecular Partners to Participate in the Evercore ISI 3rd Annual HealthCONx Conference - BioSpace
Dec 1, 2020 - Molecular Partners AG announced that Dr. Patrick Amstutz, CEO of Molecular Partners, will participate in a fireside chat at the Evercore ISI 3rd Annual...
https://www.biospace.com/arcus-biosciences-to-participate-in-the-upcoming-evercore-isi-healthconx-2021-conference
Arcus Biosciences to Participate in the Upcoming Evercore ISI HealthCONx 2021 Conference - BioSpace
Nov 22, 2021 - Arcus Biosciences, Inc. (NYSE: RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination...
https://www.biospace.com/apellis-pharmaceuticals-to-host-a-fireside-chat-at-the-6th-annual-evercore-isi-healthconx-conference
Apellis Pharmaceuticals to Host a Fireside Chat at the 6th Annual Evercore ISI HealthCONx...
Jul 30, 2024 - Apellis Pharmaceuticals, Inc., announced that the company will host a fireside chat at the 6th Annual Evercore ISI HealthCONx Conference on Tuesday, November...
https://www.marketscreener.com/quote/stock/OLD-DOMINION-FREIGHT-LINE-10317/news/Evercore-ISI-Adjusts-PT-on-Old-Dominion-Freight-Line-to-156-From-164-Maintains-In-Line-Rating-49710016/
Evercore ISI Adjusts PT on Old Dominion Freight Line to $156 From $164, Maintains In Line Rating |...
Apr 24, 2025 - Old Dominion Freight Line has an average rating of hold and mean price target of $168.65, according to analysts polled by FactSet. Price: 157.07, Change:...
https://www.marketscreener.com/news/evercore-isi-adjusts-price-target-on-regeneron-pharmaceuticals-to-875-from-750-maintains-outperfo-ce7e58d3d98efe26
Evercore ISI Adjusts Price Target on Regeneron Pharmaceuticals to $875 From $750, Maintains...
Jan 22, 2026 - Regeneron Pharmaceuticals has an average rating of overweight and mean price target of $838.46, according to analysts polled by FactSet. ...
https://www.caterpillar.com/en/news/corporate-press-releases/h/caterpillar-cfo-evercore-isi-industrial-conference-2021-webcast.html
Caterpillar | Caterpillar CFO to Participate at Evercore ISI Industrial Conference 2021 on March 2;...
https://www.gilead.com/news/news-details/2018/gilead-sciences-to-present-at-the-evercore-isi-healthconx-conference-on-tuesday-november-27
Gilead Sciences to Present at the Evercore ISI HealthCONx Conference on Tuesday, November 27
Gilead Sciences to Present at the Evercore ISI HealthCONx Conference on Tuesday November 27
https://www.biospace.com/alpine-immune-sciences-to-participate-in-fireside-chat-at-the-evercore-isi-3rd-annual-healthconx-virtual-conference
Alpine Immune Sciences to Participate in Fireside Chat at the Evercore ISI 3rd Annual HealthCONx...
Nov 25, 2020 - Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and...
https://www.marketscreener.com/news/evercore-isi-adjusts-abbvie-price-target-to-232-from-233-maintains-outperform-rating-ce7e50dedd8cff27
Evercore ISI Adjusts AbbVie Price Target to $232 From $233, Maintains Outperform Rating |...
Apr 13, 2026 - AbbVie has an average rating of overweight and mean price target of $255.12, according to analysts polled by FactSet. Price: 204.75, Change: -3.19, Percent...
https://www.marketscreener.com/news/evercore-isi-downgrades-oddity-tech-to-in-line-from-outperform-adjusts-pt-to-23-from-80-ce7e5cd9db8cfe21
Evercore ISI Downgrades ODDITY Tech to In Line From Outperform, Adjusts PT to $23 From $80 |...
https://www.marketscreener.com/news/evercore-isi-adjusts-extra-space-storage-price-target-to-149-from-150-maintains-in-line-rating-ce7e50dedd8ff62c
Evercore ISI Adjusts Extra Space Storage Price Target to $149 From $150, Maintains In Line Rating |...
Apr 13, 2026 - Extra Space Storage has an average rating of overweight and mean price target of $153.22, according to analysts polled by FactSet. Price: 137.50, Change:...
https://www.marketscreener.com/news/evercore-isi-adjusts-price-target-on-rockwell-automation-to-480-from-440-ce7f58ddd089f727
Evercore ISI Adjusts Price Target on Rockwell Automation to $480 From $440 | MarketScreener
May 6, 2026 - Rockwell Automation has an average rating of overweight and mean price target of $449.30, according to analysts polled by FactSet. ...
https://www.marketscreener.com/news/evercore-isi-adjusts-price-target-on-lowe-s-companies-to-245-from-250-maintains-in-line-rating-ce7e51dedb80f424
Evercore ISI Adjusts Price Target on Lowe's Companies to $245 From $250, Maintains In Line Rating |...
Mar 31, 2026 - Lowe's Companies has an average rating of overweight and mean price target of $288.08, according to analysts polled by FactSet. ...
https://www.biospace.com/cerevel-therapeutics-to-present-at-the-evercore-isi-3rd-annual-healthconx-virtual-conference
Cerevel Therapeutics to Present at the Evercore ISI 3rd Annual HealthCONx Virtual Conference -...
Nov 23, 2020 - Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced Chairperson and...
https://www.marketscreener.com/news/evercore-isi-adjusts-lowe-s-companies-pt-to-250-from-260-maintains-in-line-rating-ce7e5ed2d988fe2c
Evercore ISI Adjusts Lowe's Companies PT to $250 From $260, Maintains In Line Rating |...
Mar 24, 2026 - Lowe's Companies has an average rating of overweight and mean price target of $288.26, according to analysts polled by FactSet. ...
https://www.amgen.com/newsroom/press-releases/2018/11/amgen-to-present-at-the-piper-jaffray-and-evercore-isi-healthcare-conferences
Amgen To Present At the Piper Jaffray And Evercore ISI Healthcare Conferences| Amgen
the piper
https://www.prnewswire.com/news-releases/arena-pharmaceuticals-to-present-at-the-evercore-isi-healthconx-conference-on-december-1-301179350.html
Arena Pharmaceuticals to Present at the Evercore ISI HealthCONx Conference on December 1
/PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that Amit D. Munshi, the Company's President and Chief Executive Officer, is...
https://www.marketscreener.com/news/evercore-isi-adjusts-applied-materials-price-target-to-480-from-400-maintains-outperform-rating-ce7e50d9d888f026
Evercore ISI Adjusts Applied Materials Price Target to $480 From $400, Maintains Outperform Rating...
Apr 10, 2026 - Applied Materials has an average rating of Buy and mean price target of $423.50, according to analysts polled by FactSet. Price: 404.65, Change: +6.83, Percent...
https://www.theepochtimes.com/business/evercore-isi-sees-44-percent-upside-in-netflix-reiterates-rating-4344376
Evercore ISI Sees 44 Percent Upside in Netflix, Reiterates Rating | The Epoch Times
https://www.coinspeaker.com/evercore-isi-sp-500-5500-points-2022/
Evercore ISI Analyst Predicts S&P 500 May Top 5,500 Points in 2022 - Coinspeaker
https://www.insidermonkey.com/blog/evercore-isi-just-trimmed-price-target-for-nike-inc-nysenke-1314976/
Evercore ISI Just Trimmed Price Target for NIKE, Inc. (NYSE:NKE) - Insider Monkey
We recently compiled a list of the Wall Street Analysts Just Trimmed Price Targets for These 10 Stocks. In this article, we will examine how NIKE, Inc.
https://www.prnewswire.com/news-releases/aptiv-to-present-at-the-evercore-isi-global-clean-energy--transition-technologies-summit-301838484.html
Aptiv to Present at the Evercore ISI Global Clean Energy & Transition Technologies Summit
/PRNewswire/ -- Aptiv PLC (NYSE: APTV), a global technology company focused on making mobility safer, greener, and more connected, will present at the...
https://www.biospace.com/elucida-oncology-to-present-at-the-evercore-isi-2024-emerging-biotech-conference
Elucida Oncology to Present at the Evercore ISI 2024 Emerging Biotech Conference - BioSpace
Feb 16, 2024 - Elucida Oncology announced that Geno Germano, CEO and President of Elucida Oncology, will present at the Evercore ISI 2024 Emerging Biotech Conference.
https://www.biospace.com/cogent-biosciences-to-participate-in-3rd-annual-evercore-isi-healthconx-virtual-conference
Cogent Biosciences to Participate in 3rd Annual Evercore ISI HealthCONx Virtual Conference -...
Nov 20, 2020 - Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced...
to participate3rd annual